Preventive Drug-coated Balloon Angioplasty in Vulnerable Atherosclerotic Plaque (RESTORE Trial)
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1860 participants.
Also called NCT06365502
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 1,860 participants
- Registry
-
NCT06365502
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT06365502. Randomized; single masking; primary purpose treatment. Start 2024-04-16 (actual); primary completion 2027-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Preventive Drug-coated Balloon Angioplasty in Vulnerable Atherosclerotic Plaque (RESTORE Trial)
- Condition
- Acute Coronary Syndrome (ACS)
- Intervention (Device)
- Drug-coated balloon
- Intervention (Drug)
- Guideline-directed medical treatment
- Lead sponsor
- Harbin Medical University
- Collaborator
- Shanghai Shenqi Medical Technology Co., Ltd
Record details
- Record id
cardio:ct-nct06365502- Content hash
c467abd9b3fff37f197a1d0e68ff75664db51526acb169f46b92249f7a1e0108